These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25038718)

  • 1. Multi-parametric MRI findings of transitional zone prostate cancers: correlation with 3-dimensional transperineal mapping biopsy.
    Pokharel SS; Patel NU; Garg K; La Rosa FG; Arangua P; Jones C; Crawford ED
    Abdom Imaging; 2015 Jan; 40(1):143-50. PubMed ID: 25038718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours.
    Cirillo S; Petracchini M; Della Monica P; Gallo T; Tartaglia V; Vestita E; Ferrando U; Regge D
    Clin Radiol; 2008 Aug; 63(8):871-9. PubMed ID: 18625351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of prostate cancer in patients with persistently elevated PSA and tumor-negative biopsy in ambulatory care: performance of MR imaging in a multi-reader environment.
    Scheidler J; Weöres I; Brinkschmidt C; Zeitler H; Panzer S; Scharf M; Heuck A; Siebels M
    Rofo; 2012 Feb; 184(2):130-5. PubMed ID: 22274854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility.
    Hambrock T; Fütterer JJ; Huisman HJ; Hulsbergen-vandeKaa C; van Basten JP; van Oort I; Witjes JA; Barentsz JO
    Invest Radiol; 2008 Oct; 43(10):686-94. PubMed ID: 18791410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
    Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
    Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
    Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL
    AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer: evaluation with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging.
    Casciani E; Polettini E; Bertini L; Emiliozzi P; Amini M; Pansadoro V; Gualdi GF
    Radiol Med; 2004; 108(5-6):530-41. PubMed ID: 15722999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate.
    Baur AD; Maxeiner A; Franiel T; Kilic E; Huppertz A; Schwenke C; Hamm B; Durmus T
    Invest Radiol; 2014 Jun; 49(6):411-20. PubMed ID: 24598440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative predictive value of multiparametric MRI for prostate cancer detection: outcome of 5-year follow-up in men with negative findings on initial MRI studies.
    Itatani R; Namimoto T; Atsuji S; Katahira K; Morishita S; Kitani K; Hamada Y; Kitaoka M; Nakaura T; Yamashita Y
    Eur J Radiol; 2014 Oct; 83(10):1740-5. PubMed ID: 25048979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transperineal magnetic resonance image guided prostate biopsy.
    D'Amico AV; Tempany CM; Cormack R; Hata N; Jinzaki M; Tuncali K; Weinstein M; Richie JP
    J Urol; 2000 Aug; 164(2):385-7. PubMed ID: 10893591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic MRI and CAD vs. choline MRS: where is the detection level for a lesion characterisation in prostate cancer?
    Schmuecking M; Boltze C; Geyer H; Salz H; Schilling B; Wendt TG; Kloetzer KH; Marx C
    Int J Radiat Biol; 2009 Sep; 85(9):814-24. PubMed ID: 19701842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role of multifactorial evaluation of prostatic 3T MRI in patients with elevated prostatic-specific antigen levels: prospective comparison with ultrasound-guided transrectal biopsy.
    Ferda J; Kastner J; Hora M; Hes O; Fínek J; Topolčan O; Kreuzberg B
    Anticancer Res; 2013 Jun; 33(6):2791-5. PubMed ID: 23749943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced MR imaging features of the normal central zone of the prostate.
    Hansford BG; Karademir I; Peng Y; Jiang Y; Karczmar G; Thomas S; Yousuf A; Antic T; Eggener S; Oto A
    Acad Radiol; 2014 May; 21(5):569-77. PubMed ID: 24703469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early localization of recurrent prostate cancer after prostatectomy by endorectal coil magnetic resonance imaging.
    Linder BJ; Kawashima A; Woodrum DA; Tollefson MK; Karnes J; Davis BJ; Rangel LJ; King BF; Mynderse LA
    Can J Urol; 2014 Jun; 21(3):7283-9. PubMed ID: 24978358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer on computed tomography: A direct comparison with multi-parametric magnetic resonance imaging and tissue pathology.
    Jia JB; Houshyar R; Verma S; Uchio E; Lall C
    Eur J Radiol; 2016 Jan; 85(1):261-267. PubMed ID: 26526901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal ablation of prostatic cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging.
    Chen M; Hricak H; Kalbhen CL; Kurhanewicz J; Vigneron DB; Weiss JM; Carroll PR
    AJR Am J Roentgenol; 1996 May; 166(5):1157-63. PubMed ID: 8615261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric 3T MRI in the evaluation of intraglandular prostate cancer: correlation with histopathology.
    Styles C; Ferris N; Mitchell C; Murphy D; Frydenberg M; Mills J; Pedersen J; Bergen N; Duchesne G
    J Med Imaging Radiat Oncol; 2014 Aug; 58(4):439-48. PubMed ID: 24935089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer discrimination in the peripheral zone with a reduced field-of-view T(2)-mapping MRI sequence.
    Yamauchi FI; Penzkofer T; Fedorov A; Fennessy FM; Chu R; Maier SE; Tempany CM; Mulkern RV; Panych LP
    Magn Reson Imaging; 2015 Jun; 33(5):525-30. PubMed ID: 25687187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T2-weighted hypointense lesions within prostate gland: differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging--hystopatology correlations.
    Valentini AL; Gui B; Cina A; Pinto F; Totaro A; Pierconti F; Bassi PF; Bonomo L
    Eur J Radiol; 2012 Nov; 81(11):3090-5. PubMed ID: 22727777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.